ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy

Back

ESC Professional Premium Access

ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy

Session: HOT LINE 5

Topic: Pharmacotherapy

Speaker: Doctor J. Gillmore (Greater London, GB)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

5 presentations

1 follower

8 more presentations in this session

Discussant review - ATTRibute-CM

Speaker: Professor T. Damy (Creteil, FR)

Access

Slides

Video

Panel discussion - ATTRibute-CM

Access

Video

ARREST trial: Expedited transfer to a cardiac arrest center for OHCA

Speaker: Doctor T. Patterson (London, GB)

Discussant review - ARREST

Speaker: Associate Professor L. Crotti (Milan, IT)

Access

Slides

Video

Panel discussion - ARREST

Access

Video

Access the full session

HOT LINE 5

Speakers: Doctor J. Gillmore, Professor T. Damy, Doctor T. Patterson, Associate Professor L. Crotti

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy

About the speaker

Doctor Julian Gillmore

8 more presentations in this session

Discussant review - ATTRibute-CM

Panel discussion - ATTRibute-CM

ARREST trial: Expedited transfer to a cardiac arrest center for OHCA

Discussant review - ARREST

Panel discussion - ARREST

Access the full session

HOT LINE 5

About the event

ESC Congress 2023

ESC 365 is supported by